Effect of Gelatin Content on Degradation Behavior of PLLA/Gelatin Hybrid Membranes
Tissue Engineering and Regenerative Medicine · 2024
DOI: 10.1007/s13770-024-00626-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, 2024. Verfasst von Yunyoung Jang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Daelim University, 29 Imgok-ro, Dongan-gu, Anyang, 13916, South Korea. Hauptthemen laut MEDLINE: Gelatin, Polyesters, Membranes, Artificial. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of SMEs and Startups.
Abstract (Originalsprache)
BACKGROUND: Poly(L-lactic acid) (PLLA) is a biodegradable polymer (BP) that replaces conventional petroleum-based polymers. The hydrophobicity of biodegradable PLLA periodontal barrier membrane in wet state can be solved by alloying it with natural polymers. Alloying PLLA with gelatin imparts wet mechanical properties, hydrophilicity, shrinkage, degradability and biocompatibility to the polymeric matrix. METHODS: To investigate membrane performance in the wet state, PLLA/gelatin membranes were synthesized by varying the gelatin concentration from 0 to 80 wt%. The membrane was prepared by electrospinning. RESULTS: At the macroscopic scale, PLLA containing gelatin can tune the wet mechanical properties, hydrophilicity, water uptake capacity (WUC), degradability and biocompatibility of PLLA/gelatin membranes. As the gelatin content increased from 0 to 80 wt%, the dry tensile strength of the membranes increased from 6.4 to 38.9 MPa and the dry strain at break decreased from 1.7 to 0.19. PLLA/gelatin membranes with a gelatin content exceeding 40% showed excellent biocompatibility and hydrophilicity. However, dimensional change (37.5% after 7 days of soaking), poor tensile stress in wet state (3.48 MPa) and rapid degradation rate (73.7%) were observed. The highest WUC, hydrophilicity, porosity, suitable mechanical properties and biocompatibility were observed for the PLLA/40% gelatin membrane. CONCLUSION: PLLA/gelatin membranes with gelatin content less than 40% are suitable as barrier membranes for absorbable periodontal tissue regeneration due to their tunable wet mechanical properties, degradability, biocompatibility and lack of dimensional changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Daelim University, 29 Imgok-ro, Dongan-gu, Anyang, 13916, South Korea.
- Department of R&D Center, Renewmedical Co., Ltd., 28-7 Jeongju-ro, Bucheon, 14532, South Korea.
- Department of Materials Science and Engineering, Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon, 22012, South Korea.
- Department of Materials Science and Engineering, Korea Aviation University, 76 Hanggongdaehak-ro, Dukyang-gu, Goyang, 10540, South Korea. yssong@kau.ac.kr.
- Department of Biomedical Engineering, Daelim University, 29 Imgok-ro, Dongan-gu, Anyang, 13916, South Korea. duke1208@gmail.com.
- Department of R&D Center, Hass Co., Ltd, 60 Haan-ro, Gwangmyeong, 14322, South Korea. duke1208@gmail.com.
ORCID-Profile: Deuk Yong Lee
Förderung
- Ministry of SMEs and Startups
Zitieren
APA
Jang, Y., Jang, J., Kim, B. Y., Song, Y. S., & Lee, D. Y. (2024). Effect of Gelatin Content on Degradation Behavior of PLLA/Gelatin Hybrid Membranes. Tissue Engineering and Regenerative Medicine. https://doi.org/10.1007/s13770-024-00626-4
Vancouver
Jang Y, Jang J, Kim BY, Song YS, Lee DY. Effect of Gelatin Content on Degradation Behavior of PLLA/Gelatin Hybrid Membranes. Tissue Engineering and Regenerative Medicine. 2024. doi:10.1007/s13770-024-00626-4
BibTeX
@article{Jang2024,
author = {Jang, Yunyoung and Jang, Juwoong and Kim, Bae-Yeon and Song, Yo-Seung and Lee, Deuk Yong},
title = {Effect of Gelatin Content on Degradation Behavior of PLLA/Gelatin Hybrid Membranes},
journal = {Tissue Engineering and Regenerative Medicine},
year = {2024},
doi = {10.1007/s13770-024-00626-4}
}
EUVIMED